This entry was posted on Monday, February 27th, 2006 at 12:00 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
Byline: Jeetha D’Silva
Feb. 27–MUMBAI, India — Despite the VAT blues faced by the domestic pharma sector in the early part of ‘05, the market grew 8.6 percent during the year to cross Rs 23,000 crore.
Half of the top ten companies registered growth rates higher than the industry average, according to the industry audit by research agency ORG-IMS.
One of the reasons that contributed to the growth was the long monsoon, said Shailesh Gadre, MD of ORG-IMS. "This resulted in a growth of the acute therapeutic segments like cough, cold and anti-infectives," said Mr …
Read the rest of this article with a Free Trial at HighBeam Research.
Information provided by: Findarticles.com
